Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Novo Nordisk (NYSE: NVO) and Regeneron Pharmaceuticals (NASDAQ: REGN), two leading drugmakers, have underperformed for most ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who had been on GLP-1 medications for a year.

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...